Cranbury, NJ - May 06, 2015 - Key International, Inc. is pleased to announce that Frank LaSaracina has joined our growing staff as General Manager.  Frank is an industry veteran with over 30 years of executive business experience with nearly 25 years in bio-pharma.  In his new role at Key, Frank will manage financial operations, procurement, human resources, information technology, marketing, facilities, and warehousing.

"After a record breaking 2014 and significant growth year to date in 2015, we have decided to invest in our company leadership through the hiring of Frank LaSaracina as General Manager," said Valerie Ianieri, Key International CEO.  "Frank's extensive and successful experience in management operations, as well as 25 plus years in the bio-pharma industry is a perfect fit to lead Key into the future.  We are excited to have Frank on board and he will be a tremendous asset to the Key family".

Most recently, Frank founded SouthPoint Associates LCC, a consultancy focused on business development, expansion, and financing needs of bio-pharma companies.  Prior to founding SouthPoint Associates LLC, Mr. LaSaracina was Managing Director of Speedel Pharmaceuticals, Inc., the US subsidiary of Speedel Holding, the Basel based bio-pharma company that was acquired by Novartis in October of 2008. Mr. LaSaracina has extensive international experience in business development and licensing, strategic planning, and corporate development in the pharmaceutical industry. During his twenty years with Ciba/Novartis he held numerous management positions, first as director of finance in the US and then in various business development positions. Frank is a past trustee of the Oradell Board of Education as well as Newark Beth Israel Hospital and served as Trustee and Treasurer of the Biotechnology Council of New Jersey from 2004 - 2009.

Frank can be reached via: 

Email: flasaracina@keyinternational.com

Office Phone: 609-619-3685 ext. 230

Cell Phone: 609-664-6854